SUPN fund manager activity
Supernus Pharmaceuticals, Inc · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q1 2015 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | New | 7,422 | $345,197 | 0.00% | Aug 14, 2026 |
| Third Avenue Management | No change | 152,724 | $7,103,193 | 1.14% | Aug 12, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Jeremy Grantham - GMO | Sold out | — | — | 0.00% | May 14, 2026 |
| Third Avenue Management | Trimmed | 152,724 | $7,894,304 | 1.28% | May 13, 2026 |